Key facts
- This page summarizes David Tapolczay's Form 4 filing for CONDUIT PHARMACEUTICALS INC. (CDT).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 20 Nov 2024, 16:30.
David Tapolczay - 18 Nov 2024 Form 4 Insider Report for CONDUIT PHARMACEUTICALS INC. (CDT)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- CDT
- Reported as of
- 18 Nov 2024
- Net transaction value
- +$77,196
- SEC form
- 4
- Accepted by SEC
- 20 Nov 2024, 16:30:09 UTC
- Prior SEC filing
- 24 Apr 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ David Tapolczay
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
David Tapolczay filed Form 4 for CONDUIT PHARMACEUTICALS INC. (CDT) on 20 Nov 2024.
Change
- Previous filing in this sequence was filed on 24 Apr 2024.
- Current net transaction value: +$77,196.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CDT
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $77,196
- Shares
- +840,000
- Change %
- Price
- $0.0919
- Shares after
- 840,000
- Date
- 18 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 840,000
- Exercise price
- $0.0919
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents Options to purchase common stock, granted under the Issuer's 2023 Stock Incentive Plan.
Footnote F2
The Options vest as follows: (i) 50% on the grant date and (ii) 50% in equal annual installments on the first three anniversaries of the grant date.